Global Population Health Management Market Report and Forecast 2023-2031
Global Population Health Management Market Outlook
The global population health management market value was USD 31.2 billion in 2022, driven by the increase in ageing global population, and the rising cost of healthcare services across the globe. The market value is anticipated to grow at a CAGR of 16.9% during the forecast period of 2023-2031 to achieve a value of USD 126.6 billion by 2031.
Population Health Management Introduction
Population Health Management (PHM) is an emerging healthcare approach that aims to improve the health outcomes of a defined population while reducing the overall cost of healthcare. PHM encompasses a wide range of strategies, including health promotion, prevention, early intervention, care coordination, and the integration of data analytics to identify high-risk individuals and populations. By focusing on the health of an entire population, PHM seeks to address the social determinants of health and provide patient-centred care that is tailored to individual needs.
Population Health Management Market Scenario
In recent years, the global population health management market has witnessed significant growth, driven by factors such as the increasing prevalence of chronic diseases, an aging global population, and the rising cost of healthcare services. Governments, healthcare providers, and payers are increasingly adopting PHM strategies to improve patient outcomes, enhance the efficiency of healthcare systems, and control healthcare costs.
The adoption of population health management strategies has been increasing steadily due to factors such as the rising prevalence of chronic diseases, an aging global population, and the growing cost of healthcare services. Governments, healthcare providers, and payers are increasingly focusing on PHM to improve patient outcomes, enhance the efficiency of healthcare systems, and control healthcare costs.
North America: The largest market for population health management, driven by factors such as the high prevalence of chronic diseases, advanced healthcare infrastructure, and a strong focus on healthcare cost containment.
Europe: The second-largest market, with increasing demand for population health management solutions and a growing emphasis on improving healthcare outcomes and reducing healthcare costs.
Asia Pacific: Expected to witness the highest growth rate due to factors such as a rapidly aging population, increasing prevalence of chronic diseases, and growing awareness about the benefits of population health management strategies.
Population Health Management Market Segmentations
Market Breakup by Components
- Software
- Services
- Post-Sale and Maintenance Services
- Consulting Services
- Training and Education Service
- Implementation Services
- On-Premises
- Cloud Based
- Healthcare Providers
- Hospitals and Physician Groups
- Ambulatory Care Centers
- Healthcare Payers
- Public
- Private
- Others
- Hospitals Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Others
- North America
- United States of America
- Canada
- Europe
- United Kingdom
- Germany
- France
- Italy
- Others
- Asia Pacific
- China
- Japan
- India
- ASEAN
- Australia
- Others
- Latin America
- Brazil
- Argentina
- Mexico
- Others
- Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Nigeria
- South Africa
- Others
Key Trends in the Population Health Management Market
- Technological advancements: The integration of advanced technologies such as big data analytics, artificial intelligence, machine learning, and the Internet of Things (IoT) is transforming the way healthcare providers identify high-risk individuals and populations, enabling targeted interventions and personalized care.
- Digital health solutions: The use of digital health solutions, such as telehealth, remote monitoring, and electronic health records, is playing a critical role in facilitating effective population health management by improving access to care, enhancing patient engagement, and promoting data-driven decision-making.
- Value-based care models: The shift towards value-based care models, which emphasize the quality of care and patient outcomes, is driving the adoption of population health management strategies and fostering collaboration among healthcare stakeholders.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- MCKESSON CORPORATION
- Verisk Analytics, Inc
- Forward Health Group, Inc
- Health Catalyst
- Athenahealth, Inc.
- Cerner Corporation
- Medecision
- Xerox Corporation
- Allscripts Healthcare, LLC
- Fonemed
- General Electric
- HealthBI
- NXGN Management, LLC
- Optum Inc.
- Conifer Health Solutions, LLC
- IBM
- Koninklijke Philips N.V.
- Siemens Healthcare GmbH
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Population Health Management (PHM) Market Overview
- 3.1 Global Population Health Management (PHM) Market Historical Value (2016-2022)
- 3.2 Global Population Health Management (PHM) Market Forecast Value (2023-2031)
- 4 Global Population Health Management (PHM) Market Landscape
- 4.1 Global Population Health Management (PHM) Developers Landscape
- 4.1.1 Analysis by Year of Establishment
- 4.1.2 Analysis by Company Size
- 4.1.3 Analysis by Region
- 4.2 Global Population Health Management (PHM) Product Landscape
- 4.2.1 Analysis by Components
- 4.2.2 Analysis by End User
- 4.2.3 Analysis by Mode of Delivery
- 5 Global Population Health Management (PHM) Market Dynamics
- 5.1 Market Drivers and Constraints
- 5.2 SWOT Analysis
- 5.3 Porter’s Five Forces Model
- 5.4 Key Demand Indicators
- 5.5 Key Price Indicators
- 5.6 Industry Events, Initiatives, and Trends
- 5.7 Value Chain Analysis
- 6 Global Population Health Management (PHM) Market Segmentation
- 6.1 Global Population Health Management (PHM) Market by Components
- 6.1.1 Market Overview
- 6.1.2 Software
- 6.1.3 Services
- 6.1.3.1 Post-Sale and Maintenance Services
- 6.1.3.2 Consulting Services
- 6.1.3.3 Training and Education Service
- 6.1.3.4 Implementation Services
- 6.2 Global Population Health Management (PHM) Market by Mode of Delivery
- 6.2.1 Market Overview
- 6.2.2 On-Premises
- 6.2.3 Cloud Based
- 6.3 Global Population Health Management (PHM) Market by End User
- 6.3.1 Market Overview
- 6.3.2 Healthcare Providers
- 6.3.3 Hospitals and Physician Groups
- 6.3.4 Ambulatory Care Centers
- 6.3.5 Healthcare Payers
- 6.3.6 Public
- 6.3.7 Private
- 6.3.8 Others
- 6.4 Global Population Health Management (PHM) Market by Distribution Channels
- 6.4.1 Market Overview
- 6.4.2 Hospitals Pharmacies
- 6.4.3 Retail Pharmacies
- 6.4.4 Online Pharmacies
- 6.4.5 Others
- 6.5 Global Population Health Management (PHM) Market by Region
- 6.5.1 Market Overview
- 6.5.2 North America
- 6.5.3 Europe
- 6.5.4 Asia Pacific
- 6.5.5 Latin America
- 6.5.6 Middle East and Africa
- 7 North America Population Health Management (PHM) Market
- 7.1 Market Share by Country
- 7.2 United States of America
- 7.3 Canada
- 8 Europe Population Health Management (PHM) Market
- 8.1 Market Share by Country
- 8.2 United Kingdom
- 8.3 Germany
- 8.4 France
- 8.5 Italy
- 8.6 Others
- 9 Asia Pacific Population Health Management (PHM) Market
- 9.1 Market Share by Country
- 9.2 China
- 9.3 Japan
- 9.4 India
- 9.5 ASEAN
- 9.6 Australia
- 9.7 Others
- 10 Latin America Population Health Management (PHM) Market
- 10.1 Market Share by Country
- 10.2 Brazil
- 10.3 Argentina
- 10.4 Mexico
- 10.5 Others
- 11 Middle East and Africa Population Health Management (PHM) Market
- 11.1 Market Share by Country
- 11.2 Saudi Arabia
- 11.3 United Arab Emirates
- 11.4 Nigeria
- 11.5 South Africa
- 11.6 Others
- 12 Patent Analysis
- 12.1 Analysis by Type of Patent
- 12.2 Analysis by Publication year
- 12.3 Analysis by Issuing Authority
- 12.4 Analysis by Patent Age
- 12.5 Analysis by CPC Analysis
- 12.6 Analysis by Patent Valuation
- 12.7 Analysis by Key Players
- 13 Grants Analysis
- 13.1 Analysis by year
- 13.2 Analysis by Amount Awarded
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Grant Application
- 13.5 Analysis by Funding Institute
- 13.6 Analysis by NIH Departments
- 13.7 Analysis by Recipient Organization
- 14 Funding Analysis
- 14.1 Analysis by Funding Instances
- 14.2 Analysis by Type of Funding
- 14.3 Analysis by Funding Amount
- 14.4 Analysis by Leading Players
- 14.5 Analysis by Leading Investors
- 14.6 Analysis by Geography
- 15 Partnership and Collaborations Analysis
- 15.1 Analysis by Partnership Instances
- 15.2 Analysis by Type of Partnership
- 15.3 Analysis by Leading Players
- 15.4 Analysis by Geography
- 16 Regulatory Framework
- 16.1 Regulatory Overview
- 16.1.1 US FDA
- 16.1.2 EU EMA
- 16.1.3 INDIA CDSCO
- 16.1.4 JAPAN PMDA
- 16.1.5 Others
- 17 Supplier Landscape
- 17.1 MCKESSON CORPORATION
- 17.1.1 Financial Analysis
- 17.1.2 Product Portfolio
- 17.1.3 Demographic Reach and Achievements
- 17.1.4 Mergers and Acquisitions
- 17.1.5 Certifications
- 17.2 Verisk Analytics, Inc
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Mergers and Acquisitions
- 17.2.5 Certifications
- 17.3 Forward Health Group, Inc
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Mergers and Acquisitions
- 17.3.5 Certifications
- 17.4 Health Catalyst
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Mergers and Acquisitions
- 17.4.5 Certifications
- 17.5 Athenahealth, Inc.
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Mergers and Acquisitions
- 17.5.5 Certifications
- 17.6 Cerner Corporation
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Mergers and Acquisitions
- 17.6.5 Certifications
- 17.7 Medecision
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Mergers and Acquisitions
- 17.7.5 Certifications
- 17.8 Xerox Corporation
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Mergers and Acquisitions
- 17.8.5 Certifications
- 17.9 Allscripts Healthcare, LLC
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Mergers and Acquisitions
- 17.9.5 Certifications
- 17.10 Fonemed
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Mergers and Acquisitions
- 17.10.5 Certifications
- 17.11 General Electric
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Mergers and Acquisitions
- 17.11.5 Certifications
- 17.12 HealthBI
- 17.12.1 Financial Analysis
- 17.12.2 Product Portfolio
- 17.12.3 Demographic Reach and Achievements
- 17.12.4 Mergers and Acquisitions
- 17.12.5 Certifications
- 17.13 NXGN Management, LLC
- 17.13.1 Financial Analysis
- 17.13.2 Product Portfolio
- 17.13.3 Demographic Reach and Achievements
- 17.13.4 Mergers and Acquisitions
- 17.13.5 Certifications
- 17.14 Optum Inc.
- 17.14.1 Financial Analysis
- 17.14.2 Product Portfolio
- 17.14.3 Demographic Reach and Achievements
- 17.14.4 Mergers and Acquisitions
- 17.14.5 Certifications
- 17.15 Conifer Health Solutions, LLC
- 17.15.1 Financial Analysis
- 17.15.2 Product Portfolio
- 17.15.3 Demographic Reach and Achievements
- 17.15.4 Mergers and Acquisitions
- 17.15.5 Certifications
- 17.16 IBM
- 17.16.1 Financial Analysis
- 17.16.2 Product Portfolio
- 17.16.3 Demographic Reach and Achievements
- 17.16.4 Mergers and Acquisitions
- 17.16.5 Certifications
- 17.17 Koninklijke Philips N.V.
- 17.17.1 Financial Analysis
- 17.17.2 Product Portfolio
- 17.17.3 Demographic Reach and Achievements
- 17.17.4 Mergers and Acquisitions
- 17.17.5 Certifications
- 17.18 Siemens Healthcare GmbH
- 17.18.1 Financial Analysis
- 17.18.2 Product Portfolio
- 17.18.3 Demographic Reach and Achievements
- 17.18.4 Mergers and Acquisitions
- 17.18.5 Certifications
- 18 Global Population Health Management (PHM)-Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
- 20 Company Competitiveness Analysis (Additional Insight)
- 20.1 Very Small Companies
- 20.2 Small Companies
- 20.3 Mid-Sized Companies
- 20.4 Large Companies
- 20.5 Very Large Companies
- 21 Payment Methods (Additional Insight)
- 21.1 Government Funded
- 21.2 Private Insurance
- 21.3 Out-of-Pocket
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook